Search Results - Anders Castor

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011

    Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and... by Linda Olsson, Anders Castor, Mikael Behrendtz, Andrea Biloglav, Erik Forestier, Kajsa Paulsson, Bertil Johansson

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis

    Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis by Miranda Buitenhuis, Liesbeth P. Verhagen, Hanneke W. M. van Deutekom, Anders Castor, Sandra Verploegen, Leo Koenderman, Sten Eirik W. Jacobsen, Paul J. Coffer

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia

    The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia by Kajsa Paulsson, Henrik Lilljebjörn, Andrea Biloglav, Linda Olsson, Marianne Rissler, Anders Castor, Gisela Barbany, Linda Fogelstrand, Ann Nordgren, Helene Sjögren, Thoas Fioretos, Bertil Johansson

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia

    Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia by Minjun Yang, Mattias Vesterlund, Ioannis Siavelis, Larissa Helena Moura‐Castro, Anders Castor, Thoas Fioretos, Rozbeh Jafari, Henrik Lilljebjörn, Duncan T. Odom, Linda Olsson, Naveen Ravi, E. L. Woodward, Louise Harewood, Janne Lehtiö, Kajsa Paulsson

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

    Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergro... by Andrea Biondi, Martin Schrappe, Paola De Lorenzo, Anders Castor, Giovanna Lucchini, Virginie Gandemer, Rob Pieters, Jan Starý, Gabriele Escherich, Myriam Campbell, Chi Kong Li, Ajay Vora, Maurizio Aricò, Silja Röttgers, Vaskar Saha, Maria Grazia Valsecchi

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia

    Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia by Christoph Lutz, Petter Woll, Georgina Hall, Anders Castor, Hélène Dreau, Giovanni Cazzaniga, Jan Zuna, C. E. Jensen, Sally A. Clark, Andrea Biondi, Chris Mitchell, Helen Ferry, Anna Schuh, Veronica J. Buckle, Sten Eirik W. Jacobsen, Tariq Enver

    Published 2012
    Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

    Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia by Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius‐Wittsten, Linda Olsson, Christina Orsmark‐Pietras, Sofia von Palffy, Maria Askmyr, Marianne Rissler, Martin Schrappe, Gunnar Cario, Anders Castor, Cornelis Jan Pronk, Mikael Behrendtz, Felix Mitelman, Bertil Johansson, Kajsa Paulsson, Anna Andersson, Magnus Fontes, Thoas Fioretos

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial

    Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial by Andrea Biondi, Virginie Gandemer, Paola De Lorenzo, Gunnar Cario, Myriam Campbell, Anders Castor, Rob Pieters, André Baruchel, Ajay Vora, Veronica Leoni, Jan Starý, Gabriele Escherich, Chi Kong Li, Giovanni Cazzaniga, Hélène Cavé, Jutta Bradtke, Valentino Conter, Vaskar Saha, Martin Schrappe, Maria Grazia Valsecchi

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

    Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-inducti... by Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, Silja Röttgers, Jeremy Hancock, Vaskar Saha, Anders Castor, Hans O. Madsen, Virginie Gandemer, Hélène Cavé, Veronica Leoni, Rolf Köhler, Giulia Ferrari, Kirsten Bleckmann, Rob Pieters, Vincent van der Velden, Jan Starý, Jan Zuna, Gabriele Escherich, Udo zur Stadt, Maurizio Aricò, Valentino Conter, Martin Schrappe, Maria Grazia Valsecchi, Andrea Biondi

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: